DIAGNOS Statistics
Total Valuation
DIAGNOS has a market cap or net worth of CAD 33.99 million. The enterprise value is 35.64 million.
| Market Cap | 33.99M |
| Enterprise Value | 35.64M |
Important Dates
The last earnings date was Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DIAGNOS has 103.00 million shares outstanding. The number of shares has increased by 28.74% in one year.
| Current Share Class | 103.00M |
| Shares Outstanding | 103.00M |
| Shares Change (YoY) | +28.74% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 4.85% |
| Owned by Institutions (%) | n/a |
| Float | 98.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 430.28 |
| PB Ratio | -22.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.49 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.74 |
Financial Position
The company has a current ratio of 0.39
| Current Ratio | 0.39 |
| Quick Ratio | 0.34 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.59 |
| Interest Coverage | -8.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -137.41% |
| Return on Invested Capital (ROIC) | -173.20% |
| Return on Capital Employed (ROCE) | 367.49% |
| Revenue Per Employee | 3,591 |
| Profits Per Employee | -216,368 |
| Employee Count | 22 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.64% in the last 52 weeks. The beta is -0.23, so DIAGNOS's price volatility has been lower than the market average.
| Beta (5Y) | -0.23 |
| 52-Week Price Change | +19.64% |
| 50-Day Moving Average | 0.32 |
| 200-Day Moving Average | 0.27 |
| Relative Strength Index (RSI) | 57.47 |
| Average Volume (20 Days) | 331,276 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DIAGNOS had revenue of CAD 78,995 and -4.76 million in losses. Loss per share was -0.05.
| Revenue | 78,995 |
| Gross Profit | -1.30M |
| Operating Income | -4.42M |
| Pretax Income | -4.76M |
| Net Income | -4.76M |
| EBITDA | -4.40M |
| EBIT | -4.42M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 737,249 in cash and 2.39 million in debt, giving a net cash position of -1.65 million or -0.02 per share.
| Cash & Cash Equivalents | 737,249 |
| Total Debt | 2.39M |
| Net Cash | -1.65M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | -1.54M |
| Book Value Per Share | -0.02 |
| Working Capital | -1.45M |
Cash Flow
In the last 12 months, operating cash flow was -4.06 million and capital expenditures -14,299, giving a free cash flow of -4.08 million.
| Operating Cash Flow | -4.06M |
| Capital Expenditures | -14,299 |
| Free Cash Flow | -4.08M |
| FCF Per Share | -0.04 |
Margins
| Gross Margin | n/a |
| Operating Margin | -5,591.36% |
| Pretax Margin | -6,025.81% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DIAGNOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.74% |
| Shareholder Yield | -28.74% |
| Earnings Yield | -14.00% |
| FCF Yield | -12.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 24, 2019. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 24, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
DIAGNOS has an Altman Z-Score of -75.97 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -75.97 |
| Piotroski F-Score | 2 |